Projects

• RNAi Natural Yeast-based Larvicides – Indiana University, Indiana University School of Medicine and University of Notre Dame,  Bloomington, Indiana, USA
• Chromobacterium Larvicide and Adulticide – Johns Hopkins University, Baltimore, Maryland, USA
• Electronic Mosquito Barrier – Barcelona Institute For Global Health, Barcelona, Spain
• Low-Cost Treated Sandals – Ifakara Research Institute, Dar es Salaam, Tanzania
• Low-Tech Treated Fabric for Outdoor Use – Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom
• Passive Emanator for Indoor Use – QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
• Human Scent Mimic Mosquito Lure – Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
• Intelligent Trap to Enhance Zika Surveillance – São Paulo University, São Paulo, Brazil
• VectorWEB Smart Trap – Johns Hopkins University Center for Bioengineering, Innovation, and Design, Baltimore, Maryland, USA

Zika ESAC

ESAC 5 was convened to provide expert scientific, technical, regulatory and commercial advice to the Zika Grand Challenges Projects. The Committee has met twice a year since the projects’ inception. Initially, ESAC 5 were involved in establishing the Target Product Profiles (TPPs) for each project, together with the Principal Investigators. At ESAC 5 meetings, each project’s progress towards achieving the TPP was discussed between the project and ESAC 5, and guidance given.

Where relevant, ESAC 5 have arranged for extra support from consultants, especially on regulatory, toxicology and economic/commercial aspects. ESAC 5 have also suggested and established introductions to potential commercial partners.